An ACL 2017 Workshop associated with the SIGBIOMED special interest group, featuring an associated task: BioASQ ( http://www.bioasq.org/)
Vancouver, Canada, Friday August 4, 2017
- Submission deadline: Wednesday April 26, 2017 11:59 PM Eastern US
- Notification of acceptance: Monday May 22, 2017
- Camera-ready copy due from authors: Friday May 26, 2017
- Workshop: Friday August 4, 2017
Two types of submissions are invited: full papers and short papers. Submissions are due by 11:59 PM EST on Wednesday April 26, 2017.
Full papers should not exceed eight (8) pages of text, plus two pages of references. These are intended to be reports of original research. BioNLP aims to be the forum for interesting, innovative, and promising work involving biomedicine and language technology, whether or not yielding high performance at the moment. This by no means precludes our interest in and preference for mature results, strong performance, and thorough evaluation. Both types of research and combinations thereof are encouraged.
Short papers may consist of up to four (4) pages of content, plus unlimited references. Appropriate short paper topics include preliminary results, application notes, descriptions of work in progress, etc.
Electronic Submission Submissions must be electronic and in PDF format, using the Softconf START conference management system at https://www.softconf.com/acl2017/bionlp/ We strongly recommend the use of ACL LaTeX style files tailored for this year's conference. Submissions must conform to the official style guidelines. Style files and other information about paper formatting requirements are available on the conference website, http://acl2017.org/.
Submissions need to be anonymous.
Dual submission policy: papers may NOT be submitted to the BioNLP 2017 workshop if they are or will be concurrently submitted to another meeting or publication.
WORKSHOP OVERVIEW AND SCOPE
Over the course of the past fifteen years, the ACL BioNLP workshop associated with the SIGBIOMED special interest group has established itself as the primary venue for presenting foundational research in language processing for the biological and medical domains. The workshop serves as both a venue for bringing together researchers in bio- and clinical NLP and exposing these researchers to the mainstream ACL research, and a venue for informing the mainstream ACL researchers about the fast growing and important domain. The workshop will continue presenting work on a broad and interesting range of topics in NLP.
The active areas of research include, but are not limited to:
- Entity identification and normalization for a broad range of semantic categories
- Extraction of complex relations and events
- Semantic parsing
- Discourse analysis
- Anaphora /Coreference resolution
- Text mining
- Literature based discovery
- Question Answering
- Resources and novel strategies for system testing and evaluation
- Infrastructures for biomedical text mining
- Processing and annotation platforms
- Translating NLP research to practice
- Theoretical underpinnings of biomedical language processing
- Research Reproducibility
* Sophia Ananiadou, National Centre for Text Mining and University of Manchester, UK * Ion Androutsopoulos, Athens University of Economics and Business, Greece * Emilia Apostolova, Language.ai, USA * Eiji Aramaki, University of Tokyo, Japan * Alan Aronson, US National Library of Medicine * Asma Ben Abacha, US National Library of Medicine * Olivier Bodenreider, US National Library of Medicine * Leonardo Campillos Llanos, LIMSI - CNRS, France * Juan Miguel Cejuela, Technische Universität München, Germany * Kevin Bretonnel Cohen, University of Colorado School of Medicine, USA * Nigel Collier, University of Cambridge, UK * Dina Demner-Fushman, US National Library of Medicine * Patrick Gallinari, Université Pierre et Marie Curie, France * Filip Ginter, University of Turku, Finland * Graciela Gonzalez, University of Pennsylvania, USA * Cyril Grouin, LIMSI - CNRS, France * Antonio Jimeno Yepes, IBM, Melbourne Area, Australia * Aris Kosmopoulos, NCSR Demokritos, Greece * Halil Kilicoglu, US National Library of Medicine * Robert Leaman, US National Library of Medicine * Zhiyong Lu, US National Library of Medicine * Prodromes Malakasiotis, Athens University of Economics and Business, Greece * Timothy Miller, Children’s Hospital Boston, USA * Makoto Miwa, Toyota Technological Institute, Japan * Jim Mork, National Library of Medicine, USA * Danielle L Mowery, VA Salt Lake City Health Care System, USA * Yassine M'Rabet, US National Library of Medicine * Henning Müller, University of Applied Sciences, Switzerland * Claire Nédellec, INRA, France * Anastasios Nentidis, NCSR Demokritos, Athens, Greece * Aurelie Neveol, LIMSI - CNRS, France * Mariana Neves, Hasso Plattner Institute and University of Potsdam, Germany * Nhung Nguyen, The University of Manchester, UK * Naoaki Okazaki, Tohoku University, Japan * Georgios Paliouras, NCSR Demokritos, Athens, Greece * John Prager, Thomas J. Watson Research Center, IBM, USA * Sampo Pyysalo, University of Cambridge, UK * Francisco J. Ribadas-Pena, University of Vigo, Spain * Fabio Rinaldi, University of Zurich, Switzerland * Kirk Roberts, The University of Texas Health Science Center at Houston, USA * Angus Roberts, The University of Sheffield, UK * Hagit Shatkay, University of Delaware, USA * Pontus Stenetorp, University College London, UK * George Tsatsaronis, Technical University of Dresden, Germany * Karin Verspoor, The University of Melbourne, Australia * Byron C. Wallace, University of Texas at Austin, USA * W John Wilbur, US National Library of Medicine * Hai Zhao, Shanghai Jiao Tong University, Shanghai * Pierre Zweigenbaum, LIMSI - CNRS, France
Kevin Bretonnel Cohen, University of Colorado School of Medicine Dina Demner-Fushman, US National Library of Medicine Sophia Ananiadou, National Centre for Text Mining and University of Manchester, UK Jun-ichi Tsujii, National Institute of Advanced Industrial Science and Technology, Japan and University of Manchester, UK
ACL Anti-Harassment Policy
If you have any concerns or experience harassment or hostile behavior please contact Dina Demner-Fushman, Kevin Bretonnel Cohen or any current member of the ACL Executive Committee.